Padagis Launches First-To-Market Zomig Nasal Spray Ahead Of Lannett
Follows Recent Deal With Sol-Gel For Rights Related To 10 Collaborative Agreements
Less than six months into life as an independent company, former Perrigo Rx unit Padagis has realized its second generic launch, with the first-to-market entry of generic Zomig (zolmitriptan) nasal spray.
